These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 9625444

  • 21. Differential expression of galectin-3 in papillary projections of malignant and non-malignant hyperplastic thyroid lesions.
    Cvejić D, Savin S, Petrović I, Paunović I, Tatić S, Havelka M.
    Acta Chir Iugosl; 2003; 50(3):67-70. PubMed ID: 15179758
    [Abstract] [Full Text] [Related]

  • 22. Expression of Pax-8, p53 and bcl-2 in human benign and malignant thyroid diseases.
    Puglisi F, Cesselli D, Damante G, Pellizzari L, Beltrami CA, Di Loreto C.
    Anticancer Res; 2000; 20(1A):311-6. PubMed ID: 10769673
    [Abstract] [Full Text] [Related]

  • 23. Immunohistochemical study of overexpression of fibroblast growth factor-1 (FGF-1), FGF-2, and FGF receptor-1 in human malignant salivary gland tumours.
    Myoken Y, Myoken Y, Okamoto T, Sato JD, Kan M, McKeehan WL, Nakahara M, Takada K.
    J Pathol; 1996 Apr; 178(4):429-36. PubMed ID: 8691322
    [Abstract] [Full Text] [Related]

  • 24. Immunohistochemical diagnosis of papillary thyroid carcinoma.
    Cheung CC, Ezzat S, Freeman JL, Rosen IB, Asa SL.
    Mod Pathol; 2001 Apr; 14(4):338-42. PubMed ID: 11301350
    [Abstract] [Full Text] [Related]

  • 25. Expression of pituitary tumour transforming gene (PTTG) and fibroblast growth factor-2 (FGF-2) in human pituitary adenomas: relationships to clinical tumour behaviour.
    McCabe CJ, Khaira JS, Boelaert K, Heaney AP, Tannahill LA, Hussain S, Mitchell R, Olliff J, Sheppard MC, Franklyn JA, Gittoes NJ.
    Clin Endocrinol (Oxf); 2003 Feb; 58(2):141-50. PubMed ID: 12580928
    [Abstract] [Full Text] [Related]

  • 26. Isolation and characterization of human thyroid endothelial cells.
    Patel VA, Logan A, Watkinson JC, Uz-Zaman S, Sheppard MC, Ramsden JD, Eggo MC.
    Am J Physiol Endocrinol Metab; 2003 Jan; 284(1):E168-76. PubMed ID: 12388152
    [Abstract] [Full Text] [Related]

  • 27. Expression of vascular endothelial growth factor and presence of angiovascular cells in tissues from different thyroid disorders.
    Itoh A, Iwase K, Jimbo S, Yamamoto H, Yamamoto N, Kokubo M, Senda T, Nakai A, Nagagasaka A, Nagasaka T, Hibi Y, Seko T.
    World J Surg; 2010 Feb; 34(2):242-8. PubMed ID: 20041248
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Localisation and differential expression of the fibroblast growth factor receptor (FGFR) multigene family in normal and atherosclerotic human arteries.
    Hughes SE.
    Cardiovasc Res; 1996 Sep; 32(3):557-69. PubMed ID: 8881516
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Loss of heterogeneous ribonucleoprotein A(2)/B(1) expression in thyroid neoplasms.
    Bidot P, Morgan M, Zhukov T, Tannenbaum M, Tockman MS.
    Endocr Pract; 2001 Sep; 7(3):157-61. PubMed ID: 11421561
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.